Solomon Moshkevich is PRESIDENT, CLINICALDIAGNOSTICS of Natera, Inc.. Currently has a direct ownership of 149,768 shares of NTRA, which is worth approximately $24.3 Million. The most recent transaction as insider was on Feb 06, 2025, when has been sold 1,632 shares (Common Stock) at a price of $177.77 per share, resulting in proceeds of $290,120. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 150K
35.3% 3M change
23.19% 12M change
Total Value Held $24.3 Million

Solomon Moshkevich Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 06 2025
SELL
Open market or private sale
$290,120 $177.77 p/Share
1,632 Reduced 1.08%
149,768 Common Stock
Feb 05 2025
BUY
Grant, award, or other acquisition
-
3,197 Added 2.07%
151,400 Common Stock
Jan 31 2025
BUY
Grant, award, or other acquisition
-
12,720 Added 7.9%
148,203 Common Stock
Jan 29 2025
SELL
Open market or private sale
$865,290 $166.37 p/Share
5,201 Reduced 3.7%
135,483 Common Stock
Jan 22 2025
SELL
Open market or private sale
$4,187,835 $168.45 p/Share
24,861 Reduced 15.02%
140,684 Common Stock
Jan 16 2025
BUY
Grant, award, or other acquisition
-
48,548 Added 22.68%
165,545 Common Stock
Dec 23 2024
SELL
Open market or private sale
$385,129 $158.62 p/Share
2,428 Reduced 2.03%
116,997 Common Stock
Dec 23 2024
SELL
Bona fide gift
-
81 Reduced 0.07%
114,706 Common Stock
Dec 20 2024
BUY
Grant, award, or other acquisition
-
4,719 Added 3.8%
119,425 Common Stock
Dec 19 2024
SELL
Bona fide gift
-
125 Reduced 0.11%
114,787 Common Stock
Dec 09 2024
SELL
Open market or private sale
$809,294 $166.59 p/Share
4,858 Reduced 4.06%
114,912 Common Stock
Dec 09 2024
BUY
Grant, award, or other acquisition
$92,111 $10.15 p/Share
9,075 Added 7.04%
119,770 Common Stock
Oct 28 2024
SELL
Open market or private sale
$141,379 $118.21 p/Share
1,196 Reduced 1.07%
110,695 Common Stock
Oct 22 2024
SELL
Open market or private sale
$30,737 $120.07 p/Share
256 Reduced 0.23%
111,891 Common Stock
Oct 21 2024
SELL
Open market or private sale
$35,503 $120.76 p/Share
294 Reduced 0.26%
112,147 Common Stock
Jul 29 2024
SELL
Open market or private sale
$122,912 $102.77 p/Share
1,196 Reduced 1.05%
112,441 Common Stock
Jul 22 2024
SELL
Open market or private sale
$57,732 $105.16 p/Share
549 Reduced 0.48%
113,637 Common Stock
May 28 2024
SELL
Open market or private sale
$181,104 $109.96 p/Share
1,647 Reduced 1.42%
114,186 Common Stock
Apr 29 2024
SELL
Open market or private sale
$111,395 $93.14 p/Share
1,196 Reduced 1.02%
115,833 Common Stock
Apr 23 2024
SELL
Open market or private sale
$48,522 $91.38 p/Share
531 Reduced 0.45%
117,029 Common Stock
Apr 16 2024
SELL
Open market or private sale
$7,256,000 $90.7 p/Share
80,000 Reduced 40.49%
117,560 Common Stock
Mar 28 2024
SELL
Open market or private sale
$63,926 $90.42 p/Share
707 Reduced 0.36%
197,560 Common Stock
Mar 05 2024
SELL
Open market or private sale
$197,223 $87.85 p/Share
2,245 Reduced 1.12%
198,267 Common Stock
Mar 01 2024
BUY
Grant, award, or other acquisition
-
2,329 Added 1.17%
197,306 Common Stock
Feb 29 2024
BUY
Grant, award, or other acquisition
-
3,206 Added 1.57%
200,512 Common Stock
SM

Solomon Moshkevich

PRESIDENT, CLINICALDIAGNOSTICS
Austin, TX

Track Institutional and Insider Activities on NTRA

Follow Natera, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells NTRA shares.

Notify only if

Insider Trading

Get notified when an Natera, Inc. insider buys or sells NTRA shares.

Notify only if

News

Receive news related to Natera, Inc.

Track Activities on NTRA